Most cortisol-producing adenomas with overt Cushing’s syndrome are associated with mutations in the cAMP/PKA pathway (PRKACA and GNAS), which are less frequency detected in patients with PACS or ACS (23–27). This evidence concerns the gene GNAS and Cushing syndrome.